[go: up one dir, main page]

CN110680325B - Perfusion imaging method and device - Google Patents

Perfusion imaging method and device Download PDF

Info

Publication number
CN110680325B
CN110680325B CN201910992522.7A CN201910992522A CN110680325B CN 110680325 B CN110680325 B CN 110680325B CN 201910992522 A CN201910992522 A CN 201910992522A CN 110680325 B CN110680325 B CN 110680325B
Authority
CN
China
Prior art keywords
signal
magnetic resonance
layer
imaging
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910992522.7A
Other languages
Chinese (zh)
Other versions
CN110680325A (en
Inventor
吴垠
刘洁
郑海荣
刘新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Institute of Advanced Technology of CAS
Original Assignee
Shenzhen Institute of Advanced Technology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Institute of Advanced Technology of CAS filed Critical Shenzhen Institute of Advanced Technology of CAS
Priority to CN201910992522.7A priority Critical patent/CN110680325B/en
Publication of CN110680325A publication Critical patent/CN110680325A/en
Application granted granted Critical
Publication of CN110680325B publication Critical patent/CN110680325B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/004Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2576/00Medical imaging apparatus involving image processing or analysis
    • A61B2576/02Medical imaging apparatus involving image processing or analysis specially adapted for a particular organ or body part
    • A61B2576/026Medical imaging apparatus involving image processing or analysis specially adapted for a particular organ or body part for the brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

本申请适用于医学影像技术领域,提供了一种灌注成像方法及装置,包括:在标记层按照待测物质的共振频率施加饱和脉冲,饱和脉冲用于激发血液中流经所述标记层的待测物质与自由水分子进行化学交换,以完成自由水分子的信号标记;在成像层采集被信号标记的自由水分子的第一磁共振信号;当标记层未被施加饱和脉冲时,在成像层采集流经标记层后未被信号标记的自由水分子的第二磁共振信号,其中,沿着血液流动的方向,标记层位于目标区域的上游位置,成像层位于目标区域,流经标记层后的自由水分子和待测物质随着血液流入成像层;将第二磁共振信号与第一磁共振信号相减,得到差值信号;根据差值信号获取待测物质随着血液灌注到目标区域时的灌注图像。

Figure 201910992522

This application is applicable to the field of medical imaging technology, and provides a perfusion imaging method and device, including: applying a saturation pulse on the marking layer according to the resonance frequency of the substance to be measured, and the saturation pulse is used to excite the blood to be measured flowing through the marking layer. Substances chemically exchange with free water molecules to complete the signal labeling of free water molecules; the first magnetic resonance signal of signal-labeled free water molecules is collected in the imaging layer; when the marking layer is not applied with a saturation pulse, the imaging layer is collected The second magnetic resonance signal of free water molecules that have not been signal-labeled after flowing through the labeling layer, wherein, along the direction of blood flow, the labeling layer is located upstream of the target area, the imaging layer is located in the target area, and after flowing through the labeling layer Free water molecules and the substance to be tested flow into the imaging layer with the blood; the second magnetic resonance signal is subtracted from the first magnetic resonance signal to obtain a difference signal; perfusion images.

Figure 201910992522

Description

一种灌注成像方法及装置A perfusion imaging method and device

技术领域technical field

本申请涉及医学影像技术领域,尤其涉及一种灌注成像方法及装置。The present application relates to the technical field of medical imaging, in particular to a perfusion imaging method and device.

背景技术Background technique

磁共振成像(Magnetic Resonance Imaging,MRI)技术是医学影像中的核心技术。利用磁共振成像技术对血液进入组织的灌注过程进行成像(也可以称为灌注成像),获得的灌注图像使得人们能够观察血液进入组织后的灌注情况,并为评估组织的健康情况提供参考。Magnetic Resonance Imaging (MRI) technology is the core technology in medical imaging. Using magnetic resonance imaging technology to image the perfusion process of blood entering the tissue (also called perfusion imaging), the obtained perfusion images allow people to observe the perfusion of blood after entering the tissue, and provide a reference for assessing the health of the tissue.

动脉自旋标记(arterial spin labeling,ASL)追踪法为一种常见的灌注成像。通过在组织的上游血液中对自由水分子进行标记,即MRI设备通过在组织的上游血液中对自由水分子进行标记,使得自由水分子的弛豫参数发生变化。然后基于自由水分子的弛豫参数的变化获取组织的灌注图像。Arterial spin labeling (ASL) tracking is a common perfusion imaging method. By marking the free water molecules in the blood upstream of the tissue, that is, the MRI equipment marks the free water molecules in the blood upstream of the tissue, so that the relaxation parameters of the free water molecules change. A perfusion image of the tissue is then acquired based on changes in the relaxation parameters of free water molecules.

然而现有的ASL追踪法,往往获得的是自由水分子的灌注成像,仅能体现血液进入组织后的灌注情况,而无法获知血液中特定物质在组织中的灌注情况。However, the existing ASL tracking method often obtains the perfusion imaging of free water molecules, which can only reflect the perfusion of blood after entering the tissue, but cannot know the perfusion of specific substances in the blood in the tissue.

发明内容Contents of the invention

有鉴于此,本申请提供了一种灌注成像方法及装置,旨在获取血液中特定物质灌注到目标区域时的灌注图像。In view of this, the present application provides a perfusion imaging method and device, aiming at acquiring a perfusion image when a specific substance in blood is perfused into a target area.

第一方面,本申请提供一种灌注成像方法,包括:在标记层按照待测物质的共振频率施加饱和脉冲,饱和脉冲用于激发血液中流经所述标记层的待测物质与自由水分子进行化学交换,以完成自由水分子的信号标记;在成像层采集被信号标记的自由水分子的第一磁共振信号;当标记层未被施加饱和脉冲时,在成像层采集流经标记层后未被信号标记的自由水分子的第二磁共振信号,其中,沿着血液流动的方向,标记层位于目标区域的上游位置,成像层位于目标区域,流经标记层后的自由水分子和待测物质随着血液流入成像层;将第二磁共振信号与第一磁共振信号相减,得到差值信号;根据差值信号获取待测物质随着血液灌注到目标区域时的灌注图像。In the first aspect, the present application provides a perfusion imaging method, including: applying a saturation pulse on the labeling layer according to the resonance frequency of the substance to be tested, and the saturation pulse is used to excite the substance to be tested in the blood flowing through the labeling layer and free water molecules Chemical exchange to complete the signal labeling of free water molecules; the first magnetic resonance signal of the signal-labeled free water molecules is collected in the imaging layer; The second magnetic resonance signal of the free water molecules marked by the signal, wherein, along the direction of blood flow, the marking layer is located at the upstream position of the target area, the imaging layer is located at the target area, and the free water molecules flowing through the marking layer and the target area The substance flows into the imaging layer with the blood; the second magnetic resonance signal is subtracted from the first magnetic resonance signal to obtain a difference signal; according to the difference signal, the perfusion image of the substance to be tested is obtained when the substance is perfused into the target area with the blood.

采用本申请提供的灌注成像方法,MRI设备通过待测物质的共振频率对标记层施加饱和脉冲,激发待测物质与自由水分子进行化学交换,实现对应于待测物质的自由水分子的信号标记。进而在成像层采集到被信号标记前后,自由水分子的第一磁共振信号和第二磁共振信号后,MRI设备可以通过第一磁共振信号和第二磁共振信号的差值信号获取待测物质在目标区域的灌注图像,实现了针对不同待测物质获取具备特异性的灌注图像。Using the perfusion imaging method provided in this application, the MRI equipment applies saturation pulses to the labeling layer through the resonant frequency of the substance to be tested, and excites the substance to be tested to perform chemical exchange with free water molecules, thereby realizing the signal labeling of free water molecules corresponding to the substance to be tested . Furthermore, after the imaging layer collects the first magnetic resonance signal and the second magnetic resonance signal of free water molecules before and after being marked by the signal, the MRI equipment can obtain the measured The perfusion image of the substance in the target area realizes the acquisition of specific perfusion images for different substances to be tested.

可选的,该方法还包括:根据差值信号计算待测物质的化学参数。Optionally, the method further includes: calculating chemical parameters of the substance to be tested according to the difference signal.

基于该可选方式,MRI设备通过化学交换饱和转移(chemical exchangesaturation transfer,CEST)方法在标记层激发待测物质与自由水分子进行化学交换,实现对应于待测物质的自由水分子的信号标记。进而在成像层采集到被信号标记前后,自由水分子的第一磁共振信号和第二磁共振信号后,MRI设备可以通过第一磁共振信号和第二磁共振信号的差值信号计算待测物质的化学参数,实现了量化待测物质的化学参数的过程。Based on this optional method, the MRI equipment uses chemical exchange saturation transfer (chemical exchange saturation transfer, CEST) method to excite the analyte and free water molecules in the marking layer to perform chemical exchange, so as to realize the signal labeling of the free water molecules corresponding to the analyte. Furthermore, after the imaging layer collects the first magnetic resonance signal and the second magnetic resonance signal of free water molecules before and after being marked by the signal, the MRI equipment can calculate the measured The chemical parameters of the substance realize the process of quantifying the chemical parameters of the substance to be measured.

第二方面,本申请提供一种灌注成像装置,包括:标记单元,用于在标记层按照待测物质的共振频率施加饱和脉冲,饱和脉冲用于激发血液中流经所述标记层的待测物质与自由水分子进行化学交换,以完成自由水分子的信号标记;采集单元,用于在成像层采集被信号标记的自由水分子的第一磁共振信号;并当标记层未被施加饱和脉冲时,在成像层采集流经标记层后未被信号标记的自由水分子的第二磁共振信号,其中,沿着血液流动的方向,标记层位于目标区域的上游位置,成像层位于目标区域,流经标记层后的自由水分子和待测物质随着血液流入成像层;计算单元,用于将第二磁共振信号与第一磁共振信号相减,得到差值信号;成像单元,用于根据差值信号获取待测物质随着血液灌注到目标区域时的灌注图像。In a second aspect, the present application provides a perfusion imaging device, including: a labeling unit, configured to apply a saturation pulse on the labeling layer according to the resonance frequency of the substance to be tested, and the saturation pulse is used to excite the substance to be tested in the blood flowing through the labeling layer Carry out chemical exchange with free water molecules to complete the signal labeling of free water molecules; the acquisition unit is used to collect the first magnetic resonance signal of signal-labeled free water molecules on the imaging layer; and when the marking layer is not applied with a saturation pulse , the imaging layer collects the second magnetic resonance signal of free water molecules that have not been signal-labeled after flowing through the labeling layer, wherein, along the direction of blood flow, the labeling layer is located upstream of the target area, the imaging layer is located in the target area, and the flow The free water molecules and the substance to be tested flow into the imaging layer with the blood after passing through the marking layer; the calculation unit is used to subtract the second magnetic resonance signal from the first magnetic resonance signal to obtain a difference signal; the imaging unit is used to obtain a difference signal according to The difference signal acquires a perfusion image when the substance to be tested is perfused into the target area along with the blood.

可选的,计算单元,还用于根据差值信号计算待测物质的化学参数。Optionally, the calculation unit is also used to calculate the chemical parameters of the substance to be tested according to the difference signal.

可以理解的是,该灌注成像装置可以是MRI设备,或者是MRI设备中的芯片,或者是集成在MRI设备中的功能模块。其中,该芯片或者该功能模块可以位于MRI设备的控制中心(例如,控制台),控制MRI设备实现本申请提供的灌注成像方法。It can be understood that the perfusion imaging device may be an MRI device, or a chip in the MRI device, or a functional module integrated in the MRI device. Wherein, the chip or the functional module can be located in the control center (for example, console) of the MRI equipment, and control the MRI equipment to implement the perfusion imaging method provided in the present application.

可以理解的是,第二方面所述的灌注成像装置的有益效果可以参见第一方面中对应灌注成像方法的有益效果的描述,在此不再赘述。It can be understood that, for the beneficial effects of the perfusion imaging device described in the second aspect, reference may be made to the description of the corresponding beneficial effects of the perfusion imaging method in the first aspect, which will not be repeated here.

基于上述第一方面或第二方面,可选的,上述化学参数包括待测物质的化学交换速率和/或浓度。Based on the above first or second aspect, optionally, the above chemical parameters include chemical exchange rate and/or concentration of the substance to be tested.

可选的,根据差值信号计算待测物质的化学参数,包括:利用公式

Figure BDA0002238715540000031
计算化学交换速率和/或浓度;其中,CESTR表示待测物质的化学交换饱和转移率,取值为差值信号的信号强度;fs表示待测物质的浓度;kCA表示待测物质的化学交换速率;R1w表示自由水分子的纵向驰豫率;σ所述饱和脉冲的溢出因子。Optionally, calculate the chemical parameters of the substance to be tested according to the difference signal, including: using the formula
Figure BDA0002238715540000031
Calculate the chemical exchange rate and/or concentration; among them, CESTR represents the chemical exchange saturation transfer rate of the test substance, and the value is the signal intensity of the difference signal; f s represents the concentration of the test substance; k CA represents the chemical Exchange rate; R 1w represents the longitudinal relaxation rate of free water molecules; σ is the overflow factor of the saturation pulse.

可选的,在成像层采集第一磁共振信号时使用的成像参数与采集第二磁共振信号时使用的成像参数相同。Optionally, the imaging parameters used when acquiring the first magnetic resonance signal at the imaging layer are the same as the imaging parameters used when acquiring the second magnetic resonance signal.

可选的,上述待测物质可以为血液中的代谢物或者药物。Optionally, the above-mentioned substances to be tested may be metabolites or drugs in blood.

第三方面,本申请提供一种MRI设备,包括处理器、存储器以及存储在存储器中并可在处理器上运行的计算机程序,其特征在于,处理器执行计算机程序时实现如上述第一方面或第一方面的任意可选方式所述的灌注成像方法。In a third aspect, the present application provides an MRI device, including a processor, a memory, and a computer program stored in the memory and operable on the processor, characterized in that, when the processor executes the computer program, the above-mentioned first aspect or The perfusion imaging method described in any optional mode of the first aspect.

第四方面,本申请提供一种计算机可读存储介质,计算机可读存储介质存储有计算机程序,其特征在于,计算机程序被处理器执行时实现如第一方面或者第一方面的任一可选方式所述的灌注成像方法。In a fourth aspect, the present application provides a computer-readable storage medium, which stores a computer program, and is characterized in that, when the computer program is executed by a processor, any optional Methods described perfusion imaging method.

第五方面,本申请提供一种计算机程序产品,当计算机程序产品在控制设备上运行时,使得控制设备执行上述第一方面或者第一方面的任一可选方式所述的灌注成像方法。In a fifth aspect, the present application provides a computer program product. When the computer program product is run on a control device, the control device is made to execute the perfusion imaging method described in the first aspect or any optional manner of the first aspect.

可以理解的是,上述第三方面至第五方面的有益效果可以参见上述第一方面中的相关描述,在此不再赘述。It can be understood that, for the beneficial effects of the above third aspect to the fifth aspect, reference may be made to the relevant description in the above first aspect, which will not be repeated here.

附图说明Description of drawings

为了更清楚地说明本申请中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其他的附图。In order to illustrate the technical solution in this application more clearly, the accompanying drawings that need to be used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the accompanying drawings in the following description are only some implementations of the present invention For example, those skilled in the art can also obtain other drawings based on these drawings without paying creative labor.

图1是本申请提供的一种灌注成像方法的一个实施例的流程图;Fig. 1 is a flowchart of an embodiment of a perfusion imaging method provided by the present application;

图2是本申请提供的一种标记层与成像层的示意图;Fig. 2 is a schematic diagram of a marking layer and an imaging layer provided by the present application;

图3是本申请提供的一种灌注图像的示意图;Fig. 3 is a schematic diagram of a perfusion image provided by the present application;

图4是本申请提供的一种灌注成像方法的另一个实施例的流程图;Fig. 4 is a flowchart of another embodiment of a perfusion imaging method provided by the present application;

图5是本申请提供的一种灌注成像装置的结构示意图;Fig. 5 is a schematic structural diagram of a perfusion imaging device provided by the present application;

图6是本申请提供的一种MRI设备的结构示意图。Fig. 6 is a schematic structural diagram of an MRI device provided by the present application.

具体实施方式Detailed ways

以下描述中,为了说明而不是为了限定,提出了诸如特定系统结构、技术之类的具体细节,以便透彻理解本申请。然而,本领域的技术人员应当清楚,在没有这些具体细节的其它实施例中也可以实现本发明。在其它情况中,省略对众所周知的系统、装置、电路以及方法的详细说明,以免不必要的细节妨碍本发明的描述。In the following description, for purposes of illustration rather than limitation, specific details, such as specific system architectures and techniques, are set forth in order to provide a thorough understanding of the present application. It will be apparent, however, to one skilled in the art that the invention may be practiced in other embodiments without these specific details. In other instances, detailed descriptions of well-known systems, devices, circuits, and methods are omitted so as not to obscure the description of the present invention with unnecessary detail.

在本申请说明书中描述的参考“一个实施例”或“一些实施例”等意味着在本申请的一个或多个实施例中包括结合该实施例描述的特定特征、结构或特点。由此,在本说明书中的不同之处出现的语句“在一个实施例中”、“在一些实施例中”、“在其他一些实施例中”、“在另外一些实施例中”等不是必然都参考相同的实施例,而是意味着“一个或多个但不是所有的实施例”,除非是以其他方式另外特别强调。术语“包括”、“包含”、“具有”及它们的变形都意味着“包括但不限于”,除非是以其他方式另外特别强调。Reference to "one embodiment" or "some embodiments" or the like in the specification of the present application means that a particular feature, structure, or characteristic described in connection with the embodiment is included in one or more embodiments of the present application. Thus, appearances of the phrases "in one embodiment," "in some embodiments," "in other embodiments," "in other embodiments," etc. in various places in this specification are not necessarily All refer to the same embodiment, but mean "one or more but not all embodiments" unless specifically stated otherwise. The terms "including", "comprising", "having" and variations thereof mean "including but not limited to", unless specifically stated otherwise.

另外,在本申请说明书和所附权利要求书的描述中,术语“第一”、“第二”、“第三”等仅用于区分描述,而不能理解为指示或暗示相对重要性。In addition, in the description of the specification and appended claims of the present application, the terms "first", "second", "third" and so on are only used to distinguish descriptions, and should not be understood as indicating or implying relative importance.

为了说明本申请提供的技术方案,下面通过具体实施例来进行说明。In order to illustrate the technical solutions provided by the present application, specific examples are used below to illustrate.

参见图1,为本申请提供的一种灌注成像方法的一个实施例的流程图,该方法包括:Referring to FIG. 1, it is a flow chart of an embodiment of a perfusion imaging method provided by the present application, the method comprising:

步骤101,MRI设备在标记层按照待测物质的共振频率施加饱和脉冲,饱和脉冲用于激发血液中流经标记层的待测物质与自由水分子进行化学交换,以完成自由水分子的信号标记。In step 101, the MRI equipment applies a saturation pulse to the labeling layer according to the resonance frequency of the substance to be tested, and the saturation pulse is used to excite the substance to be tested in the blood flowing through the labeling layer to chemically exchange with free water molecules, so as to complete the signal labeling of free water molecules.

其中,标记层位于目标区域动脉血流上游,即沿着血液流动的方向,标记层位于目标区域的上游位置。目标区域为需要获取灌注图像的区域,例如,脑组织、心肌组织、肾组织等。示例性的,如图2所示,标记层在脑组织的动脉血流上游的位置,箭头表示血液流动的方向。Wherein, the marking layer is located upstream of the arterial blood flow in the target area, that is, along the direction of blood flow, and the marking layer is located upstream of the target area. The target area is an area where perfusion images need to be obtained, for example, brain tissue, myocardial tissue, kidney tissue, and the like. Exemplarily, as shown in FIG. 2 , the position of the marking layer is upstream of the arterial blood flow of the brain tissue, and the arrow indicates the direction of blood flow.

在本申请中,待测物质可以是血液中能够与自由水分子发生化学交换作用的物质,包括血液中的代谢物或者进入血液中的药物。其中,血液中的待测物质与自由水分子进行化学交换是指待测物质中的可交换质子(例如氢质子)与自由水分子的氢质子进行能量交换。In this application, the substance to be tested may be a substance in the blood that can undergo chemical exchange with free water molecules, including metabolites in the blood or drugs that enter the blood. Wherein, the chemical exchange between the test substance in the blood and the free water molecules refers to the energy exchange between the exchangeable protons (such as hydrogen protons) in the test substance and the hydrogen protons of the free water molecules.

MRI设备可以基于化学交换饱和转移(chemical exchange saturationtransfer,CEST)方法,在标记层按照待测物质的共振频率施加饱和脉冲,也就是说,MRI设备基于待测物质中的可交换质子的共振频率向流经标记层的待测物质中的可交换质子施加饱和脉冲,使得可交换质子饱和。饱和的可交换质子与自由水分子的氢质子进行化学交换,将一部分能量转移到自由水分子的氢质子上,从而使得自由水分子的氢质子的磁共振信号从第二磁共振信号(即被信号标记前的磁共振信号)减小为第一磁共振信号,进而完成自由水分子的信号标记。The MRI equipment can be based on the chemical exchange saturation transfer (chemical exchange saturation transfer, CEST) method, and a saturation pulse is applied to the marking layer according to the resonant frequency of the substance to be measured. The exchangeable protons in the substance to be tested flowing through the labeling layer apply a saturation pulse to saturate the exchangeable protons. The saturated exchangeable protons chemically exchange with the hydrogen protons of free water molecules, and a part of the energy is transferred to the hydrogen protons of free water molecules, so that the magnetic resonance signal of the hydrogen protons of free water molecules is changed from the second magnetic resonance signal (that is, by The magnetic resonance signal before signal labeling) is reduced to the first magnetic resonance signal, and then the signal labeling of free water molecules is completed.

步骤102,MRI设备在成像层采集被信号标记的自由水分子的第一磁共振信号。Step 102, the MRI equipment collects the first magnetic resonance signal of the signal-labeled free water molecule on the imaging layer.

其中,成像层位于目标区域(例如,如图2所示的成像层所处位置),用于在血液流入目标区域,对目标区域进行灌注时,采集灌注数据,便于后续生成灌注图像。Wherein, the imaging layer is located in the target area (for example, where the imaging layer is located as shown in FIG. 2 ), and is used to collect perfusion data when blood flows into the target area to perfuse the target area, so as to facilitate subsequent generation of perfusion images.

在本申请中,自由水分子流经施加了饱和脉冲的标记层时,被信号标记。然后当被信号标记的自由水分子随着血液流入目标区域的成像层时,MRI设备即可采集被信号标记的自由水分子的第一磁共振信号。In this application, free water molecules are signal-labeled as they flow through the labeling layer to which a saturation pulse is applied. Then, when the signal-labeled free water molecules flow into the imaging layer of the target area along with the blood, the MRI equipment can collect the first magnetic resonance signals of the signal-labeled free water molecules.

步骤103,当标记层未被施加饱和脉冲时,MRI设备在成像层采集流经标记层后未被信号标记的自由水分子的第二磁共振信号。Step 103 , when no saturation pulse is applied to the marking layer, the MRI equipment collects second magnetic resonance signals of free water molecules that have not been signal-marked after flowing through the marking layer on the imaging layer.

在本申请中,MRI设备需要基于相同的成像参数采集第一磁共振信号和第二磁共振信号。即,MRI设备在成像层采集第一磁共振信号时使用的成像参数与采集第二磁共振信号时使用的成像参数相同,从而保证后续获准确的差值信号。其中,成像参数可以包括采集轨迹,重建参数等。In this application, the MRI equipment needs to acquire the first magnetic resonance signal and the second magnetic resonance signal based on the same imaging parameters. That is, the imaging parameters used by the MRI equipment when acquiring the first magnetic resonance signal at the imaging layer are the same as the imaging parameters used when acquiring the second magnetic resonance signal, so as to ensure subsequent accurate difference signals. Wherein, the imaging parameters may include acquisition trajectory, reconstruction parameters and the like.

值得说明的时,MRI设备可以先对标记层施加饱和脉冲,采集被信号标记的自由水分子的第一磁共振信号,然后关闭饱和脉冲,采集未被信号标记的自由水分字的第二磁共振信号。也可以先采集未被信号标记的自由水分子的第二磁共振信号,然后对标记层施加饱和脉冲并采集被信号标记的自由水分子的第一磁共振信号。即MRI设备可以先执行步骤101-102,再执行步骤S103,也可以先执行步骤S103,再执行步骤101-102。It is worth noting that the MRI equipment can first apply a saturation pulse to the labeling layer to collect the first magnetic resonance signal of the free water molecule marked by the signal, and then turn off the saturation pulse to collect the second magnetic resonance signal of the free water molecule not marked by the signal Signal. It is also possible to first collect the second magnetic resonance signal of the free water molecule not marked with the signal, and then apply a saturation pulse to the marking layer and collect the first magnetic resonance signal of the free water molecule marked with the signal. That is to say, the MRI device may first execute steps 101-102, and then execute step S103, or may first execute step S103, and then execute steps 101-102.

步骤104,MRI设备将第二磁共振信号与第一磁共振信号相减,得到差值信号。Step 104, the MRI equipment subtracts the second magnetic resonance signal from the first magnetic resonance signal to obtain a difference signal.

MRI设备用第二磁共振信号减去第一磁共振信号,得到差值信号。The MRI equipment subtracts the first magnetic resonance signal from the second magnetic resonance signal to obtain a difference signal.

步骤105,MRI设备根据差值信号获取待测物质随着血液灌注到目标区域时的灌注图像。Step 105, the MRI equipment acquires a perfusion image when the substance to be tested is perfused into the target area along with the blood according to the difference signal.

示例性的,以目标区域为脑组织为例。如图3所示,MRI设备在标记层不施加饱和脉冲,基于成像层采集到的第二磁共振信号生成的图像为图像1。MRI设备在标记层施加饱和脉冲,基于成像层采集到的第一磁共振信号生成的图像为图像2。MRI设备基于第二磁共振信号和第一磁共振信号的差值信号生成的待测物质在脑组织的灌注图像。也可以认为,将图像1和图像2相减,即可获取待测物质灌注到脑组织时的灌注图像。可以看出,MRI设备获得的灌注图像可以直观的看出待测物质在脑组织中的灌注情况。Exemplarily, the target area is brain tissue as an example. As shown in FIG. 3 , the MRI equipment does not apply a saturation pulse to the marker layer, and the image generated based on the second magnetic resonance signal collected in the imaging layer is image 1 . The MRI equipment applies a saturation pulse to the marking layer, and the image generated based on the first magnetic resonance signal collected in the imaging layer is image 2 . The MRI device generates a perfusion image of the substance to be tested in the brain tissue based on the difference signal between the second magnetic resonance signal and the first magnetic resonance signal. It can also be considered that by subtracting image 1 and image 2, the perfusion image when the substance to be tested is perfused into the brain tissue can be obtained. It can be seen that the perfusion image obtained by the MRI equipment can intuitively see the perfusion situation of the substance to be tested in the brain tissue.

综上可知,采用本申请提供的灌注方法,MRI设备通过CEST方法在标记层激发待测物质与自由水分子进行化学交换,实现自由水分子的信号标记。进而在成像层采集到被信号标记前后,自由水分子的第一磁共振信号和第二磁共振信号后,MRI设备可以通过第一磁共振信号和第二磁共振信号的差值信号获取待测物质在目标区域的灌注图像,实现了针对不同待测物质获取具备特异性的灌注图像。In summary, with the perfusion method provided in this application, the MRI equipment uses the CEST method to excite the substance to be tested on the labeling layer to perform chemical exchange with free water molecules, thereby realizing the signal labeling of free water molecules. Furthermore, after the imaging layer collects the first magnetic resonance signal and the second magnetic resonance signal of free water molecules before and after being marked by the signal, the MRI equipment can obtain the measured The perfusion image of the substance in the target area realizes the acquisition of specific perfusion images for different substances to be tested.

在一个实施例中,MRI设备在得到差值信号之后,还可以根据差值信号进一步量化待测物质的化学参数。例如,参见图4,为本申请提供的一种灌注成像方法的另一个实施例的流程图,如图4所示,本实施例与图1对应的实施例的区别在于,在步骤205之后该方法还包括步骤206,本实施例中的步骤201~步骤205与图1对应的实施例中的步骤101~步骤105相同,具体请参阅图1对应的实施例的相关描述,此处不赘述。步骤206具体如下:In an embodiment, after the MRI equipment obtains the difference signal, it can further quantify the chemical parameters of the substance to be tested according to the difference signal. For example, see FIG. 4 , which is a flow chart of another embodiment of a perfusion imaging method provided by the present application. As shown in FIG. 4 , the difference between this embodiment and the embodiment corresponding to FIG. 1 is that after step 205 the The method further includes step 206. Steps 201 to 205 in this embodiment are the same as steps 101 to 105 in the embodiment corresponding to FIG. 1 . For details, please refer to the relevant description of the embodiment corresponding to FIG. 1 , and details are not repeated here. Step 206 is specifically as follows:

步骤206,MRI设备根据差值信号计算待测物质的化学参数。Step 206, the MRI equipment calculates the chemical parameters of the substance to be tested according to the difference signal.

其中,待测物质的化学参数可以是待测物质的浓度和/或化学交换速率,或者其他化学参数。Wherein, the chemical parameter of the substance to be tested may be the concentration and/or chemical exchange rate of the substance to be tested, or other chemical parameters.

示例性的,当待测物质的化学参数为待测物质的浓度和/或化学交换速率时,在一种可能的实现方式中,MRI设备可以继续对标记层施加的饱和脉冲的能量大小,计算待测物质的浓度和/或化学交换速率。Exemplarily, when the chemical parameter of the substance to be tested is the concentration and/or the chemical exchange rate of the substance to be tested, in a possible implementation, the MRI equipment may continue to apply the energy of the saturation pulse to the marking layer, and calculate The concentration and/or chemical exchange rate of the substance to be measured.

例如,MRI设备可以利用如下公式(1)计算化学交换速率和/或浓度。For example, the MRI device can calculate chemical exchange rates and/or concentrations using equation (1) below.

Figure BDA0002238715540000081
Figure BDA0002238715540000081

其中,fs表示待测物质的浓度;kCA表示待测物质的化学交换速率;R1w表示自由水分子的纵向驰豫率;α表示待测物质的饱和效率。σ所述饱和脉冲的溢出因子。CESTR表示待测物质的化学交换饱和转移率(chemical exchange saturation transfer ratio),取值为差值信号的信号强度。MRI设备将对目标区域采集到的每个差值信号的信号强度逐个带入公式(1)进行计算,最终得到fs和/或kCAAmong them, f s represents the concentration of the analyte; k CA represents the chemical exchange rate of the analyte; R 1w represents the longitudinal relaxation rate of free water molecules; α represents the saturation efficiency of the analyte. σ is the overflow factor of the saturation pulse. CESTR represents the chemical exchange saturation transfer ratio of the substance to be measured, and is taken as the signal intensity of the difference signal. The MRI equipment will bring the signal strength of each difference signal collected in the target area into formula (1) one by one for calculation, and finally obtain f s and/or k CA .

综上所述,采用本申请提供的灌注成像方法,MRI设备通过CEST方法在标记层激发待测物质与自由水分子进行化学交换,实现对应于待测物质的自由水分子的信号标记。进而在成像层采集到被信号标记前后,自由水分子的第一磁共振信号和第二磁共振信号后,MRI设备可以通过第一磁共振信号和第二磁共振信号的差值信号计算待测物质的化学参数,实现了量化待测物质的化学参数的过程。To sum up, using the perfusion imaging method provided in this application, the MRI equipment uses the CEST method to excite the substance to be tested and free water molecules in the labeling layer for chemical exchange, so as to realize the signal labeling of the free water molecules corresponding to the substance to be tested. Furthermore, after the imaging layer collects the first magnetic resonance signal and the second magnetic resonance signal of free water molecules before and after being marked by the signal, the MRI equipment can calculate the measured The chemical parameters of the substance realize the process of quantifying the chemical parameters of the substance to be measured.

应理解,上述实施例中各步骤的序号的大小并不意味着执行顺序的先后,各过程的执行顺序应以其功能和内在逻辑确定,而不应对本申请的实施过程构成任何限定。It should be understood that the sequence numbers of the steps in the above embodiments do not mean the order of execution, and the execution order of each process should be determined by its functions and internal logic, and should not constitute any limitation to the implementation process of the present application.

对应于上文实施例所述的灌注成像方法,图5示出了本申请提供的灌注成像装置的结构框图,为了便于说明,仅示出了与本申请相关的部分。Corresponding to the perfusion imaging method described in the above embodiments, Fig. 5 shows a structural block diagram of a perfusion imaging device provided by the present application, and for the convenience of description, only the parts relevant to the present application are shown.

参照图5,该灌注图像装置包括:标记单元51、采集单元52、计算单元53以及成像单元54。Referring to FIG. 5 , the perfusion imaging device includes: a marking unit 51 , an acquisition unit 52 , a calculation unit 53 and an imaging unit 54 .

标记单元51,用于在标记层按照待测物质的共振频率施加饱和脉冲,饱和脉冲用于激发血液中流经标记层的待测物质与自由水分子进行化学交换,以完成自由水分子的信号标记。The marking unit 51 is used to apply a saturation pulse to the marking layer according to the resonant frequency of the substance to be measured, and the saturation pulse is used to excite the substance to be measured in the blood flowing through the marking layer to chemically exchange with free water molecules, so as to complete the signal marking of free water molecules .

采集单元52,用于在成像层采集被信号标记的自由水分子的第一磁共振信号;并当标记层未被施加饱和脉冲时,在成像层采集流经标记层后未被信号标记的自由水分子的第二磁共振信号,其中,沿着血液流动的方向,标记层位于目标区域的上游位置,成像层位于目标区域,流经标记层后的自由水分子和待测物质随着血液流入成像层。The acquisition unit 52 is used to acquire the first magnetic resonance signal of the free water molecules marked by the signal on the imaging layer; The second magnetic resonance signal of water molecules, wherein, along the direction of blood flow, the marking layer is located upstream of the target area, the imaging layer is located in the target area, and the free water molecules and substances to be tested flow into the marking layer with the blood imaging layer.

计算单元53,用于将第二磁共振信号与第一磁共振信号相减,得到差值信号。The computing unit 53 is configured to subtract the second magnetic resonance signal from the first magnetic resonance signal to obtain a difference signal.

成像单元54,用于根据差值信号获取待测物质随着血液灌注到目标区域时的灌注图像。The imaging unit 54 is configured to acquire a perfusion image when the substance to be tested is perfused into the target area along with the blood according to the difference signal.

可选的,计算单元53,还用于根据差值信号计算待测物质的化学参数。Optionally, the calculation unit 53 is also used to calculate chemical parameters of the substance to be tested according to the difference signal.

标记单元51在标记层施加饱和脉冲的具体方式、采集单元42采集第一磁共振信号和第二磁共振信号的具体方式、计算单元53计算差值信号和化学参数的具体方式、成像单元54获取待测物质在目标区域的灌注图像的具体方式,可以参考上文中图1-4所示实施例中的相关描述,此处不在赘述。The specific way in which the marking unit 51 applies a saturation pulse on the marking layer, the specific way in which the acquisition unit 42 acquires the first magnetic resonance signal and the second magnetic resonance signal, the specific way in which the calculation unit 53 calculates the difference signal and chemical parameters, and the acquisition by the imaging unit 54 For the specific manner of the perfusion image of the substance to be tested in the target area, reference may be made to the relevant descriptions in the above embodiments shown in FIGS. 1-4 , which will not be repeated here.

在本申请中,该灌注图像装置可以是MRI设备,或者是MRI设备中的芯片,或者是集成在MRI设备中的功能模块。其中,该芯片或者该功能模块可以位于MRI设备的控制中心(例如,控制台),控制MRI设备实现本申请提供的灌注成像方法。In this application, the perfusion imaging device may be an MRI device, or a chip in the MRI device, or a functional module integrated in the MRI device. Wherein, the chip or the functional module can be located in the control center (for example, console) of the MRI equipment, and control the MRI equipment to implement the perfusion imaging method provided in the present application.

参见图6,为本申请提供的一种MRI设备,包括:至少一个处理器60(图6中仅示出一个)处理器、存储器61以及存储在存储器61中并可在至少一个处理器60上运行的计算机程序62,处理器60执行计算机程序62时实现上述灌注成像方法实施例中的步骤。例如,处理器60执行计算机程序62时实现上述步骤101-105,以及步骤201-206。Referring to Fig. 6, a kind of MRI equipment provided for the present application comprises: at least one processor 60 (only one is shown in Fig. 6 ) processor, memory 61 and be stored in memory 61 and can be on at least one processor 60 The running computer program 62, when the processor 60 executes the computer program 62, implements the steps in the above embodiment of the perfusion imaging method. For example, when the processor 60 executes the computer program 62, the above steps 101-105 and steps 201-206 are realized.

所称处理器60可以是中央处理单元(Central Processing Unit,CPU),该处理器60还可以是其他通用处理器、数字信号处理器(Digital Signal Processor,DSP)、专用集成电路(Application Specific Integrated Circuit,ASIC)、现成可编程门阵列(Field-Programmable Gate Array,FPGA)或者其他可编程逻辑器件、分立门或者晶体管逻辑器件、分立硬件组件等。通用处理器可以是微处理器或者该处理器也可以是任何常规的处理器等。The so-called processor 60 may be a central processing unit (Central Processing Unit, CPU), and the processor 60 may also be other general-purpose processors, a digital signal processor (Digital Signal Processor, DSP), an application specific integrated circuit (Application Specific Integrated Circuit) , ASIC), off-the-shelf programmable gate array (Field-Programmable Gate Array, FPGA) or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc. A general-purpose processor may be a microprocessor, or the processor may be any conventional processor, or the like.

存储器61在一些实施例中可以是MRI设备的内部存储单元,例如MRI设备的硬盘或内存。存储器61在另一些实施例中也可以是MRI设备的外部存储设备,例如MRI设备上配备的插接式硬盘,智能存储卡(Smart Media Card,SMC),安全数字(Secure Digital,SD)卡,闪存卡(Flash Card)等。进一步地,存储器61还可以既包括MRI设备的内部存储单元也包括外部存储设备。存储器61用于存储操作系统、应用程序、引导装载程序(BootLoader)、数据以及其他程序等,例如计算机程序62的程序代码等。存储器61还可以用于暂时地存储已经输出或者将要输出的数据。The memory 61 may be an internal storage unit of the MRI device in some embodiments, such as a hard disk or memory of the MRI device. The memory 61 may also be an external storage device of the MRI device in other embodiments, such as a plug-in hard disk equipped on the MRI device, a smart memory card (Smart Media Card, SMC), a secure digital (Secure Digital, SD) card, Flash card (Flash Card), etc. Further, the memory 61 may also include both an internal storage unit of the MRI device and an external storage device. The memory 61 is used to store an operating system, application programs, boot loader (BootLoader), data and other programs, such as program codes of the computer program 62 . The memory 61 can also be used to temporarily store data that has been output or will be output.

本领域技术人员可以理解,图6仅仅是MRI设备的举例,并不构成对MRI设备的限定,可以包括比图示更多或更少的部件,或者组合某些部件,或者不同的部件,例如还可以包括输入输出设备、网络接入设备、扫描仪等。Those skilled in the art can understand that Fig. 6 is only an example of MRI equipment, and does not constitute a limitation to MRI equipment, and may include more or less components than shown in the figure, or combine some components, or different components, for example It can also include input and output devices, network access devices, scanners, etc.

所属领域的技术人员可以清楚地了解到,为了描述的方便和简洁,仅以上述各功能单元、模块的划分进行举例说明,实际应用中,可以根据需要而将上述功能分配由不同的功能单元、模块完成,即将所述装置的内部结构划分成不同的功能单元或模块,以完成以上描述的全部或者部分功能。实施例中的各功能单元、模块可以集成在一个处理单元中,也可以是各个单元单独物理存在,也可以两个或两个以上单元集成在一个单元中,上述集成的单元既可以采用硬件的形式实现,也可以采用软件功能单元的形式实现。另外,各功能单元、模块的具体名称也只是为了便于相互区分,并不用于限制本申请的保护范围。上述系统中单元、模块的具体工作过程,可以参考前述方法实施例中的对应过程,在此不再赘述。Those skilled in the art can clearly understand that for the convenience and brevity of description, only the division of the above-mentioned functional units and modules is used for illustration. In practical applications, the above-mentioned functions can be assigned to different functional units, Completion of modules means that the internal structure of the device is divided into different functional units or modules to complete all or part of the functions described above. Each functional unit and module in the embodiment may be integrated into one processing unit, or each unit may exist separately physically, or two or more units may be integrated into one unit, and the above-mentioned integrated units may adopt hardware It can also be implemented in the form of software functional units. In addition, the specific names of the functional units and modules are only for the convenience of distinguishing each other, and are not used to limit the protection scope of the present application. For the specific working process of the units and modules in the above system, reference may be made to the corresponding process in the foregoing method embodiments, and details will not be repeated here.

在上述实施例中,对各个实施例的描述都各有侧重,某个实施例中没有详述或记载的部分,可以参见其它实施例的相关描述。In the above-mentioned embodiments, the descriptions of each embodiment have their own emphases, and for parts that are not detailed or recorded in a certain embodiment, refer to the relevant descriptions of other embodiments.

本领域普通技术人员可以意识到,结合本文中所公开的实施例描述的各示例的单元及算法步骤,能够以电子硬件、或者计算机软件和电子硬件的结合来实现。这些功能究竟以硬件还是软件方式来执行,取决于技术方案的特定应用和设计约束条件。专业技术人员可以对每个特定的应用来使用不同方法来实现所描述的功能,但是这种实现不应认为超出本发明的范围。Those skilled in the art can appreciate that the units and algorithm steps of the examples described in conjunction with the embodiments disclosed herein can be implemented by electronic hardware, or a combination of computer software and electronic hardware. Whether these functions are executed by hardware or software depends on the specific application and design constraints of the technical solution. Those skilled in the art may use different methods to implement the described functions for each specific application, but such implementation should not be regarded as exceeding the scope of the present invention.

在本发明所提供的实施例中,应该理解到,所揭露的装置/终端设备和方法,可以通过其它的方式实现。例如,以上所描述的装置/终端设备实施例仅仅是示意性的,例如,所述模块或单元的划分,仅仅为一种逻辑功能划分,实际实现时可以有另外的划分方式,例如多个单元或组件可以结合或者可以集成到另一个系统,或一些特征可以忽略,或不执行。另一点,所显示或讨论的相互之间的耦合或直接耦合或通讯连接可以是通过一些接口,装置或单元的间接耦合或通讯连接,可以是电性,机械或其它的形式。In the embodiments provided in the present invention, it should be understood that the disclosed apparatus/terminal equipment and method may be implemented in other ways. For example, the device/terminal device embodiments described above are only illustrative. For example, the division of the modules or units is only a logical function division. In actual implementation, there may be other division methods, such as multiple units Or components may be combined or may be integrated into another system, or some features may be omitted, or not implemented. In another point, the mutual coupling or direct coupling or communication connection shown or discussed may be through some interfaces, and the indirect coupling or communication connection of devices or units may be in electrical, mechanical or other forms.

所述作为分离部件说明的单元可以是或者也可以不是物理上分开的,作为单元显示的部件可以是或者也可以不是物理单元,即可以位于一个地方,或者也可以分布到多个网络单元上。可以根据实际的需要选择其中的部分或者全部单元来实现本实施例方案的目的。The units described as separate components may or may not be physically separated, and the components shown as units may or may not be physical units, that is, they may be located in one place, or may be distributed to multiple network units. Part or all of the units can be selected according to actual needs to achieve the purpose of the solution of this embodiment.

另外,在本发明各个实施例中的各功能单元可以集成在一个处理单元中,也可以是各个单元单独物理存在,也可以两个或两个以上单元集成在一个单元中。上述集成的单元既可以采用硬件的形式实现,也可以采用软件功能单元的形式实现。In addition, each functional unit in each embodiment of the present invention may be integrated into one processing unit, each unit may exist separately physically, or two or more units may be integrated into one unit. The above-mentioned integrated units can be implemented in the form of hardware or in the form of software functional units.

所述集成的模块/单元如果以软件功能单元的形式实现并作为独立的产品销售或使用时,可以存储在一个计算机可读取存储介质中。基于这样的理解,本发明实现上述实施例方法中的全部或部分流程,也可以通过计算机程序来指令相关的硬件来完成,所述的计算机程序可存储于一计算机可读存储介质中,该计算机程序在被处理器执行时,可实现上述各个方法实施例的步骤。If the integrated module/unit is realized in the form of a software function unit and sold or used as an independent product, it can be stored in a computer-readable storage medium. Based on this understanding, the present invention realizes all or part of the processes in the methods of the above embodiments, and can also be completed by instructing related hardware through a computer program. The computer program can be stored in a computer-readable storage medium, and the computer When the program is executed by the processor, the steps in the above-mentioned various method embodiments can be realized.

相应的,本申请提供一种计算机可读存储介质,计算机可读存储介质存储有计算机程序,计算机程序被处理器执行时实现如本申请提供的灌注成像方法。Correspondingly, the present application provides a computer-readable storage medium, where a computer program is stored in the computer-readable storage medium, and when the computer program is executed by a processor, the perfusion imaging method as provided in the present application is implemented.

本申请还提供一种计算机程序产品,当计算机程序产品在MRI设备上运行时,使得MRI设备执行本申请提供的灌注成像方法。The present application also provides a computer program product, which, when the computer program product runs on the MRI equipment, causes the MRI equipment to execute the perfusion imaging method provided in the present application.

其中,所述计算机程序包括计算机程序代码,所述计算机程序代码可以为源代码形式、对象代码形式、可执行文件或某些中间形式等。所述计算机可读介质可以包括:能够携带所述计算机程序代码的任何实体或装置、记录介质、U盘、移动硬盘、磁碟、光盘、计算机存储器、只读存储器(ROM,Read-Only Memory)、随机存取存储器(RAM,Random AccessMemory)、电载波信号、电信信号以及软件分发介质等。需要说明的是,所述计算机可读介质包含的内容可以根据司法管辖区内立法和专利实践的要求进行适当的增减,例如在某些司法管辖区,根据立法和专利实践,计算机可读介质不包括电载波信号和电信信号。Wherein, the computer program includes computer program code, and the computer program code may be in the form of source code, object code, executable file or some intermediate form. The computer-readable medium may include: any entity or device capable of carrying the computer program code, a recording medium, a U disk, a removable hard disk, a magnetic disk, an optical disk, a computer memory, and a read-only memory (ROM, Read-Only Memory) , Random Access Memory (RAM, Random Access Memory), electrical carrier signal, telecommunication signal, and software distribution medium, etc. It should be noted that the content contained in the computer-readable medium may be appropriately increased or decreased according to the requirements of legislation and patent practice in the jurisdiction. For example, in some jurisdictions, computer-readable media Excludes electrical carrier signals and telecommunication signals.

以上所述实施例仅用以说明本申请的技术方案,而非对其限制;尽管参照前述实施例对本申请进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本申请各实施例技术方案的精神和范围,均应包含在本申请的保护范围之内。The above-described embodiments are only used to illustrate the technical solutions of the present application, rather than to limit them; although the present application has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: it can still implement the foregoing embodiments Modifications to the technical solutions described in the examples, or equivalent replacements for some of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the various embodiments of the application, and should be included in the Within the protection scope of this application.

Claims (10)

1.一种灌注成像方法,其特征在于,包括:1. A perfusion imaging method, comprising: 在标记层按照待测物质的共振频率施加饱和脉冲,所述饱和脉冲用于激发血液中流经所述标记层的所述待测物质与自由水分子进行化学交换,以完成所述自由水分子的信号标记;A saturation pulse is applied to the marking layer according to the resonant frequency of the substance to be measured, and the saturation pulse is used to excite the substance to be measured in the blood flowing through the marking layer to perform chemical exchange with free water molecules, so as to complete the separation of the free water molecules signal mark; 在成像层采集被信号标记的自由水分子的第一磁共振信号;acquiring a first magnetic resonance signal of signal-labeled free water molecules at the imaging layer; 当所述标记层未被施加所述饱和脉冲时,在所述成像层采集流经所述标记层后未被信号标记的自由水分子的第二磁共振信号,其中,沿着血液流动的方向,所述标记层位于目标区域的上游位置,所述成像层位于所述目标区域,流经所述标记层后的自由水分子和所述待测物质随着血液流入所述成像层,所述第一磁共振信号和所述第二磁共振信号基于相同的成像参数采集;When the saturation pulse is not applied to the marking layer, a second magnetic resonance signal of free water molecules that are not signal-labeled after flowing through the marking layer is collected on the imaging layer, wherein, along the direction of blood flow , the marking layer is located upstream of the target area, the imaging layer is located in the target area, free water molecules and the analyte flowing through the marking layer flow into the imaging layer with blood, the The first magnetic resonance signal and the second magnetic resonance signal are acquired based on the same imaging parameters; 将所述第二磁共振信号与所述第一磁共振信号相减,得到差值信号;subtracting the second magnetic resonance signal from the first magnetic resonance signal to obtain a difference signal; 根据所述差值信号获取所述待测物质随着血液灌注到所述目标区域时的灌注图像。Acquiring a perfusion image when the substance to be tested is perfused into the target area along with the blood according to the difference signal. 2.根据权利要求1所述的方法,其特征在于,所述方法还包括:2. The method according to claim 1, characterized in that the method further comprises: 根据所述差值信号计算所述待测物质的化学参数。The chemical parameters of the substance to be tested are calculated according to the difference signal. 3.根据权利要求2所述的方法,其特征在于,所述化学参数包括所述待测物质的化学交换速率和/或浓度。3. The method according to claim 2, wherein the chemical parameters include the chemical exchange rate and/or concentration of the substance to be tested. 4.根据权利要求3所述的方法,其特征在于,所述根据所述差值信号计算所述待测物质的化学参数,包括:4. The method according to claim 3, wherein the calculating the chemical parameters of the substance to be tested according to the difference signal comprises: 利用公式
Figure FDA0003986152230000011
计算化学交换速率和/或浓度;
use the formula
Figure FDA0003986152230000011
Calculate chemical exchange rates and/or concentrations;
其中,CESTR表示所述待测物质的化学交换饱和转移率,取值为所述差值信号的信号强度;fs表示所述待测物质的浓度;kCA表示所述待测物质的化学交换速率;R1w表示自由水分子的纵向驰豫率;σ所述饱和脉冲的溢出因子;α表示所述待测物质的饱和效率。Wherein, CESTR represents the chemical exchange saturation transfer rate of the analyte, which is the signal intensity of the difference signal; f s represents the concentration of the analyte; k CA represents the chemical exchange of the analyte Rate; R 1w represents the longitudinal relaxation rate of free water molecules; σ overflow factor of the saturation pulse; α represents the saturation efficiency of the analyte.
5.根据权利要求1所述的方法,其特征在于,在所述成像层采集所述第一磁共振信号时使用的成像参数与采集所述第二磁共振信号时使用的成像参数相同。5 . The method according to claim 1 , wherein the imaging parameters used when acquiring the first magnetic resonance signal at the imaging layer are the same as the imaging parameters used when acquiring the second magnetic resonance signal. 6.根据权利要求1-5任一项所述的方法,其特征在于,所述待测物质为血液中的代谢物或者药物。6. The method according to any one of claims 1-5, wherein the substance to be tested is a metabolite or a drug in blood. 7.一种灌注成像装置,其特征在于,包括:7. A perfusion imaging device, comprising: 标记单元,用于在标记层按照待测物质的共振频率施加饱和脉冲,所述饱和脉冲用于激发血液中流经所述标记层的所述待测物质与自由水分子进行化学交换,以完成所述自由水分子的信号标记;The marking unit is used to apply a saturation pulse on the marking layer according to the resonant frequency of the substance to be tested, and the saturation pulse is used to excite the substance to be tested in the blood flowing through the marking layer to perform chemical exchange with free water molecules, so as to complete the A signal label for free water molecules; 采集单元,用于在成像层采集被信号标记的自由水分子的第一磁共振信号;并当所述标记层未被施加所述饱和脉冲时,在所述成像层采集流经所述标记层后未被信号标记的自由水分子的第二磁共振信号,其中,沿着血液流动的方向,所述标记层位于目标区域的上游位置,所述成像层位于所述目标区域,流经所述标记层后的自由水分子和所述待测物质随着血液流入所述成像层,所述第一磁共振信号和所述第二磁共振信号基于相同的成像参数采集;an acquisition unit, configured to acquire a first magnetic resonance signal of a signal-labeled free water molecule on the imaging layer; and when the saturation pulse is not applied to the marker layer, acquire the signal flowing through the marker layer The second magnetic resonance signal of free water molecules that are not labeled by the signal, wherein, along the direction of blood flow, the labeling layer is located upstream of the target area, the imaging layer is located in the target area, and flows through the The free water molecules behind the marking layer and the substance to be measured flow into the imaging layer with the blood, and the first magnetic resonance signal and the second magnetic resonance signal are collected based on the same imaging parameters; 计算单元,用于将所述第二磁共振信号与所述第一磁共振信号相减,得到差值信号;a calculation unit, configured to subtract the second magnetic resonance signal from the first magnetic resonance signal to obtain a difference signal; 成像单元,用于根据所述差值信号获取所述待测物质随着血液灌注到所述目标区域时的灌注图像。An imaging unit, configured to acquire a perfusion image of the substance to be tested when the substance is perfused into the target area along with the blood according to the difference signal. 8.根据权利要求7所述的灌注成像装置,其特征在于,8. The perfusion imaging device according to claim 7, characterized in that, 所述计算单元,还用于根据所述差值信号计算所述待测物质的化学参数。The calculation unit is further configured to calculate chemical parameters of the substance to be tested according to the difference signal. 9.一种磁共振成像MRI设备,包括处理器、存储器以及存储在所述存储器中并可在所述处理器上运行的计算机程序,其特征在于,所述处理器执行所述计算机程序时实现如权利要求1至6任一项所述的灌注成像方法。9. A magnetic resonance imaging MRI device, comprising a processor, a memory, and a computer program stored in the memory and operable on the processor, characterized in that, when the processor executes the computer program, it realizes The perfusion imaging method according to any one of claims 1 to 6. 10.一种计算机可读存储介质,所述计算机可读存储介质存储有计算机程序,其特征在于,所述计算机程序被处理器执行时实现如权利要求1至6任一项所述的灌注成像方法。10. A computer-readable storage medium, the computer-readable storage medium storing a computer program, characterized in that, when the computer program is executed by a processor, the perfusion imaging according to any one of claims 1 to 6 is realized method.
CN201910992522.7A 2019-10-18 2019-10-18 Perfusion imaging method and device Active CN110680325B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910992522.7A CN110680325B (en) 2019-10-18 2019-10-18 Perfusion imaging method and device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910992522.7A CN110680325B (en) 2019-10-18 2019-10-18 Perfusion imaging method and device

Publications (2)

Publication Number Publication Date
CN110680325A CN110680325A (en) 2020-01-14
CN110680325B true CN110680325B (en) 2023-02-14

Family

ID=69113184

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910992522.7A Active CN110680325B (en) 2019-10-18 2019-10-18 Perfusion imaging method and device

Country Status (1)

Country Link
CN (1) CN110680325B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115267632B (en) * 2022-05-12 2025-03-18 上海东软医疗科技有限公司 Magnetic resonance perfusion imaging method, device, computer equipment and readable storage medium

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107133957A (en) * 2017-04-20 2017-09-05 西门子医疗系统有限公司 Magnetic resonance image processing method and device
WO2019067615A1 (en) * 2017-09-26 2019-04-04 The Board Of Trustees Of The University Of Illinois Systems and methods for bo-corrected arterial spin labeling magnetic resonance imaging

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278925B2 (en) * 2008-03-26 2012-10-02 The General Hospital Corporation Method for relaxation-compensated fast multi-slice chemical exchange saturation transfer MRI
WO2014099463A1 (en) * 2012-12-18 2014-06-26 The General Hospital Corporation System and method for sensitivity-enhanced multi-echo chemical exchange saturation transfer (mecest) magentic resonance imaging

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107133957A (en) * 2017-04-20 2017-09-05 西门子医疗系统有限公司 Magnetic resonance image processing method and device
WO2019067615A1 (en) * 2017-09-26 2019-04-04 The Board Of Trustees Of The University Of Illinois Systems and methods for bo-corrected arterial spin labeling magnetic resonance imaging

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
化学交换饱和转移技术原理及应用进展;闫爽等;《磁共振成像》;20160430;第7卷(第4期);241-248 *

Also Published As

Publication number Publication date
CN110680325A (en) 2020-01-14

Similar Documents

Publication Publication Date Title
Gatidis et al. The autopet challenge: towards fully automated lesion segmentation in oncologic PET/CT imaging
Seehaus et al. Histological validation of DW-MRI tractography in human postmortem tissue
Korfiatis et al. Automated segmentation of hyperintense regions in FLAIR MRI using deep learning
Muschelli et al. Neuroconductor: an R platform for medical imaging analysis
US9858665B2 (en) Medical imaging device rendering predictive prostate cancer visualizations using quantitative multiparametric MRI models
CN120177327A (en) Intelligent measurement method and image processing system based on image processing and machine learning
Park et al. Diffusion and perfusion MRI radiomics obtained from deep learning segmentation provides reproducible and comparable diagnostic model to human in post-treatment glioblastoma
CN113466769B (en) Multichannel magnetic resonance imaging method, device, equipment and storage medium
Taimouri et al. Spatially constrained incoherent motion method improves diffusion‐weighted MRI signal decay analysis in the liver and spleen
CN110680325B (en) Perfusion imaging method and device
CN110824398A (en) Chemical exchange characteristic quantification method and apparatus
WO2021115055A1 (en) Method and device for generating artery input function curve
WO2023202662A1 (en) Cest magnetic resonance analysis method based on permuted random forest, and apparatus
Karthik et al. Comprehensive assessment of imaging quality of artificial intelligence-assisted compressed sensing-based MR images in routine clinical settings
Klepaczko et al. A multi-layer perceptron network for perfusion parameter estimation in DCE-MRI studies of the healthy kidney
Virarkar et al. Current update on PET/MRI in gynecological malignancies—a review of the literature
Noh et al. Deep learning algorithms for automatic segmentation of acute cerebral infarcts on diffusion-weighted images: effects of training data sample size, transfer learning, and data features
Caron et al. Collegiate athlete brain data for white matter mapping and network neuroscience
WO2021072730A1 (en) Perfusion imaging method and apparatus
Bekheet et al. Cardiac Fibrosis Automated Diagnosis Based on FibrosisNet Network Using CMR Ischemic Cardiomyopathy
CN118094362A (en) Thyroid follicle classification model training device, classification device and equipment
CN117872246A (en) Ideal CEST signal quantifying method, apparatus, device and storage medium
Tward et al. 3d multimodal histological atlas and coordinate framework for the mouse brain and head
Zimmerman et al. Histology to 3D in vivo MR registration for volumetric evaluation of MRgFUS treatment assessment biomarkers
CN116758285A (en) Semi-supervised image segmentation method based on artificial intelligence and related equipment

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant